Mark Livingston Biography and Net Worth

CEO of Progyny


Mark is a seasoned finance executive with demonstrated success transitioning entrepreneurial businesses to high growth corporate entities. Prior to joining Progyny, Mark was the Integration Management Officer at Scripps Networks driving its merger with Discovery Communications. He also served as SVP Finance and CFO International at Scripps, and in senior finance roles at Emerson Reid, Emdeon and Hess.

What is Mark S. Livingston's net worth?

The estimated net worth of Mark S. Livingston is at least $1.16 million as of April 1st, 2024. Mr. Livingston owns 50,119 shares of Progyny stock worth more than $1,164,264 as of May 3rd. This net worth evaluation does not reflect any other assets that Mr. Livingston may own. Additionally, Mr. Livingston receives an annual salary of $749,560.00 as CEO at Progyny. Learn More about Mark S. Livingston's net worth.

How old is Mark S. Livingston?

Mr. Livingston is currently 58 years old. There are 4 older executives and no younger executives at Progyny. The oldest executive at Progyny is Mr. David J. Schlanger, Executive Chairman, who is 65 years old. Learn More on Mark S. Livingston's age.

What is Mark S. Livingston's salary?

As the CEO of Progyny, Inc., Mr. Livingston earns $749,560.00 per year. There are 2 executives that earn more than Mr. Livingston. The highest earning executive at Progyny is Mr. Peter Anevski, CEO & Director, who commands a salary of $1,090,000.00 per year. Learn More on Mark S. Livingston's salary.

How do I contact Mark S. Livingston?

The corporate mailing address for Mr. Livingston and other Progyny executives is 1359 BROADWAY, NEW YORK NY, 10018. Progyny can also be reached via phone at 212-888-3124 and via email at investors@progyny.com. Learn More on Mark S. Livingston's contact information.

Has Mark S. Livingston been buying or selling shares of Progyny?

Mark S. Livingston has not been actively trading shares of Progyny during the last ninety days. Most recently, Mark S. Livingston sold 11,165 shares of the business's stock in a transaction on Monday, April 1st. The shares were sold at an average price of $37.62, for a transaction totalling $420,027.30. Following the completion of the sale, the chief financial officer now directly owns 50,119 shares of the company's stock, valued at $1,885,476.78. Learn More on Mark S. Livingston's trading history.

Who are Progyny's active insiders?

Progyny's insider roster includes Peter Anevski (COO), Jennifer Bealer (EVP), Kevin Gordon (Director), Lisa Greenbaum (EVP), Mark Livingston (CEO), Norman Payson (Director), David Schlanger (Executive Chairman), Cheryl Scott (Director), and Michael Sturmer (President). Learn More on Progyny's active insiders.

Are insiders buying or selling shares of Progyny?

In the last twelve months, Progyny insiders bought shares 2 times. They purchased a total of 359,500 shares worth more than $5,235,560.00. In the last twelve months, insiders at the sold shares 2 times. They sold a total of 10,492 shares worth more than $312,406.18. The most recent insider tranaction occured on December, 26th when Chairman David J Schlanger bought 150,000 shares worth more than $2,202,000.00. Insiders at Progyny own 9.4% of the company. Learn More about insider trades at Progyny.

Information on this page was last updated on 12/26/2024.

Mark S. Livingston Insider Trading History at Progyny

See Full Table

Mark S. Livingston Buying and Selling Activity at Progyny

This chart shows Mark S Livingston's buying and selling at Progyny by year and by quarter.

Skip ChartChart Data in Insider Trading History Table
2022202320242025$0bought$0soldQ2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1Q2-$500k$0$500kTotal Insider BuyingTotal Insider Selling

Progyny Company Overview

Progyny logo
Progyny, Inc., a benefits management company, specializes in fertility and family building benefits solutions in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists. The company also offers Progyny Rx, an integrated pharmacy benefits solution that provides its members with access to the medications needed during their treatment. In addition, it provides assistance service programs where various services can be offered through a reimbursement program, including adoption, surrogacy, doula, and travel reimbursement when travel is required to receive medical services. The company was formerly known as Auxogyn, Inc. and changed its name to Progyny, Inc. in 2015. Progyny, Inc. was incorporated in 2008 and is headquartered in New York, New York.
Read More

Today's Range

Now: $23.23
Low: $22.86
High: $23.38

50 Day Range

MA: $21.90
Low: $19.82
High: $23.23

2 Week Range

Now: $23.23
Low: $13.39
High: $33.84

Volume

721,327 shs

Average Volume

1,743,620 shs

Market Capitalization

$1.99 billion

P/E Ratio

40.05

Dividend Yield

N/A

Beta

1.33